Hypoglycemic effects of a sesquiterpene glycoside isolated from leaves of loquat (Eriobotrya japonica (Thunb.) Lindl.)

Phytomedicine

Volumn 15, Issue 1-2, 2008, Pages 98-102

  Chen, J ^a   Li, W L ^a   Wu, J L ^a   Ren, B R ^a   Zhang, H Q ^a  

^a INSTITUTE OF BOTANY   (China)

Author keywords

Hypoglycemic effects; Loquat Eriobotrya japonica (Thunb.) Lindl. ; Nerolidol 3 O l rhamnopyranosyl(1 4) l rhamnopyranosyl(1 2) l rhamnopyranosyl(1 6) d glucopyranoside; Sesquiterpene glycoside

Indexed keywords

ALLOXAN; GLICLAZIDE; GLYCOSIDE; NEROLIDOL 3 O ALPHA LEVO RHAMNOPYRANOSYL(1-4) ALPHA LEVO RHAMNOPYRANOSYL (1-2)[ALPHA LEVO RHAMNOPYRANOSYL(1-6)] BETA DEXTRO GLUCOPYRANOSIDE; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; LOQUAT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADMINISTRATION, ORAL; ALLOXAN; ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE SEQUENCE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ERIOBOTRYA; GLICLAZIDE; GLYCOSIDES; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, INBRED ICR; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; PLANT LEAVES; SESQUITERPENES;

ANIMALIA; ERIOBOTRYA JAPONICA; MUS; ROSACEAE;

EID: 37349088088     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.12.014     Document Type: Article

References (9)

1. A Group of Editors for Chinese Materia Medica, 1996. Chinese Materia Medica. Science and Technology Press, Shanghai, 777pp.
2. Abraira C., Colwell J.A., Nuttall F.Q., Sawin C.T., Nagel N.J., and Comstock J.P. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in type II diabetes. Diabetes Care 18 (1995) 1113-1123
3. American Diabetes Association and National Institutes of Diabetes Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care 25 (2002) 742-749
4. De Fronzo R.A. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 131 (1999) 281-303
5. De Tommasi N., De Simone F., and Aquino R. Plant metabolites, new sesquiterpene glycosides from Eriobotrya japonica. J. Nat. Prod. 53 (1990) 810-815
6. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
7. Gaster B., and Hirsch I.B. The effects of improved glycemic control on complications in type 2 diabetes. Arch. Intern. Med. 158 (1998) 134-140
8. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., and Motoyoshi S. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28 (1995) 103-117
9. Skyler J.S. Diabetes mellitus: pathogenesis and treatment strategies. J. Med. Chem. 47 (2004) 4113-4117